A potentially gamechanging technology from Cambridge that transforms regional anaesthesia into a single operator procedure and improves patient safety is being demonstrated live by a renowned clinician at Arab Health 2022 later this month.
The procedure is being carried out in a state-of-the-art operating theatre located in the UK Pavilion at the Dubai showcase by Dr Emad Fawzy, a consultant anaesthetist at the flagship Sheikh Khalifa Medical City in Abu Dhabi.
SAFIRA®, tipped to revolutionise regional anaesthesia globally, has been developed by medical device company Medovate in collaboration with clinicians from the NHS.
The device gives anaesthetists full control of injection, as well as enhancing confidence through a built-in safety mechanism to automatically limit injection pressure to less than 20psi – helping to reduce the risk of nerve injury in patients.
Dr Fawzy, who was previously based at the Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust in the UK as part of the team of clinical specialists behind the pioneering device, will demonstrate SAFIRA® and share his experiences of introducing the pioneering technology into clinical practice.
Dr Fawzy said: “The device is already in use by clinicians across the world and feedback has been overwhelmingly positive, including reports of how the technology facilitates hydro-dissection and a reduction in the amount of local anaesthetic required for a successful block. It is a great privilege to be able to showcase such an innovative device in the Middle East.”
Recent studies have sparked new enthusiasm for regional anaesthesia across the world with evidence indicating improved clinical outcomes. During the current pandemic, the European and American Societies of Regional Anesthesia have both produced joint COVID-19 recommendations stating that regional anaesthesia should be preferred over general anaesthesia as the need to minimise aerosol-generating procedures (AGPs) took precedence.
As demand for such procedures increase globally, SAFIRA® has the potential to make a significant impact in areas such as the MENA region. The device recently won the HSJ Patient Safety Innovation of the Year 2021.
Chris Rogers, sales and marketing director at Medovate, said: “We are thrilled to be demonstrating our innovative device for regional anaesthesia, SAFIRA®, at this year’s Arab Health.
“The unique technology has been developed in collaboration with clinical innovators within the NHS and it is a fantastic demonstration of how the UK’s NHS can be a true driver for innovation.
“We are excited to be joining the ABHI UK Pavilion to offer the world-class audiences at Arab Health a chance to see our revolutionary device up close and in action.”
• The demonstration of SAFIRA® will take place on Tuesday 25th January 11-30 – 12-30.